 | Up a level |
Bohlender, J.; Nussberger, J.; Amstutz, C.; Birkhäuser, F.; Thalmann, G. N.; Imboden, H. (2013). Unilateral renal denervation and the renal kallikrein-bradykinin system in the rat. Annales de cardiologie et d'angéiologie, 62(3), pp. 144-148. Elsevier Masson 10.1016/j.ancard.2013.04.014
Scholz, M.; Zehender, M.; Thalmann, G. N.; Borner, M.; Thöni, H.; Studer, U. E. (2002). Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Annals of oncology, 13(1), pp. 121-124. Oxford University Press 10.1093/annonc/mdf003
Burkhard, F. C.; Markwalder, R.; Thalmann, G. N.; Studer, U. E. (1997). Immunohistochemical determination of p53 overexpression. Urological research, 25(S1), S31-S35. Springer-Verlag 10.1007/BF00942045
Borgström, A.; Kiener, M.; Kappel, S.; Hauert, B.; Delalande, C.; Zoni, E.; Reymond, J.; Thalmann, G. N.; Peinelt, C.; Kruithof-de Julio, M. (15 March 2019). Investigation of TRPM4 and store-operated calcium entry in prostate cancer cell systems and a primary prostate cancer stem cell model. European Urology Supplements, 18(1), e342-e342. Elsevier https://doi.org/10.1016/S1569-9056(19)30254-4
La Manna, F.; Staender, L.; Gray, P. C.; Zoni, E.; Karkampouna, S.; Thalmann, G. N.; Kruithof-de Julio, M. (15 March 2019). Cripto blockade reduces prostate cancer reactivity to microenvironment and metastatic potential. European Urology Supplements, 18(1), e1156-e1156. Elsevier 10.1016/S1569-9056(19)30833-4
Borgström, A.; Kiener, M.; Kappel, S.; Hauert, B.; Delalande, C.; Zoni, E.; Reymond, J.-L.; Thalmann, G. N.; Peinelt, C.; Kruithof-de Julio, M. (2019). Investigation of TRPM4 and store-operated calcium entry in prostate cancer cell systems and a primary prostate cancer stem cell model. Der Urologe, 58(Suppl 1), S42-S42. Springer https://doi.org/10.1007/s00120-019-1018-y
Kiener, M.; Chen, L.; Krebs, M.; Grosjean, J.; Klima, I.; Herreiner, P.; Kalogiro, C.; Riedmiller, H.; Kneitz, B.; Thalmann, G. N.; Snaar-Jagalska, E.; Spahn, E.; Kruithof-de Julio, M.; Zoni, E. (2019). miR-221-5p decreases proliferation and migration in human prostate cancer cells and reduces tumor burden in vivo. Der Urologe, 58(Suppl 1), S40-S40. Springer
Kiener, M.; Karkampouna, S.; Thalmann, G. N.; Seiler, R.; Kruithof-de Julio, M. (2019). Characterisation of bladder cancer drug responses in organoids and ex vivo models. Der Urologe, 58(Suppl 1), S101-S101. Springer
Fleischmann, Achim; Saramaki, O.; Visakorpi, T.; Zlobec, I.; Thalmann, G. N. (2013). Prostate Cancer Cells with TMPRSS2-ERG Gene Fusion or ERG Overexpression Are Not Selected in the Metastatic Process. Laboratory investigation, 93(S1), 210A. Nature Publishing Group
Fleischmann, A.; Saramaki, O.; Visakorpi, T.; Zlobec, I.; Thalmann, G. N. (2013). Prostate Cancer Cells with TMPRSS2-ERG Gene Fusion or ERG Overexpression Are Not Selected in the Metastatic Process. Modern pathology, 26(S2), p. 210. Nature Publishing Group
